The Bcl-3 model exhibited diminished activation of JNK and ERK compared to the wild type at 40 weeks of age in parallel to attenuation of cell proliferation and HCC, while at the earlier time point JNK activation was enhanced in Bcl3Hep mice. The gene discussed is BCL3; the disease is hepatocellular carcinoma.